TACROLIMUS

TACROLIMUS was reported 93325 times

TACROLIMUS is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 TRANSPLANTATION ASSOCIATED FOOD ALLERGY 69 0.9324
1 MALACOPLAKIA 79 0.8876
2 PHAEOHYPHOMYCOSIS 180 0.8219
3 RENAL GRAFT INFECTION 98 0.8167
4 POST TRANSPLANT DISTAL LIMB SYNDROME 153 0.8095
5 SMOOTH MUSCLE CELL NEOPLASM 139 0.7898
6 POLYOMAVIRUS-ASSOCIATED NEPHROPATHY 1024 0.7841
7 TRICHODYSPLASIA SPINULOSA 189 0.7590
8 DELAYED GRAFT FUNCTION 327 0.7535
9 PANCREAS TRANSPLANT REJECTION 117 0.7358
10 TRANSPLANT DYSFUNCTION 906 0.7231
11 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 1269 0.6361
12 RHODOCOCCUS INFECTION 63 0.6238
13 IMMUNOSUPPRESSANT DRUG LEVEL DECREASED 559 0.6156
14 CHRONIC ALLOGRAFT NEPHROPATHY 345 0.6128
15 HUMAN POLYOMAVIRUS INFECTION 198 0.6018
16 LIVER TRANSPLANT REJECTION 839 0.5913
17 POLYOMAVIRUS VIRAEMIA 185 0.5892
18 TRANSPLANT REJECTION 3237 0.5854
19 HEART TRANSPLANT REJECTION 474 0.5845
20 PARVOVIRUS B19 INFECTION 185 0.5640
21 POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER 1544 0.5508
22 LUNG TRANSPLANT REJECTION 250 0.5459
23 BILIARY ANASTOMOSIS COMPLICATION 59 0.5413
24 COMPLICATIONS OF TRANSPLANTED KIDNEY 906 0.5370
25 PHAEHYPHOMYCOSIS 76 0.5241
26 RENAL TRANSPLANT FAILURE 319 0.5153
27 BK VIRUS INFECTION 976 0.5118
28 ALTERNARIA INFECTION 97 0.5105
29 ACANTHAMOEBA INFECTION 63 0.4922
30 PANCREAS TRANSPLANT 67 0.4786
31 TRICHOPHYTOSIS 64 0.4604
32 COMPLICATIONS OF TRANSPLANTED HEART 74 0.4512
33 COMPLICATIONS OF TRANSPLANTED LUNG 80 0.4494
34 KIDNEY TRANSPLANT REJECTION 1700 0.4487
35 UREAPLASMA INFECTION 73 0.4398
36 GRAFT LOSS 262 0.4389
37 CYTOMEGALOVIRUS VIRAEMIA 1000 0.4264
38 COMPLICATIONS OF TRANSPLANTED LIVER 130 0.4235
39 NEUTROPHIL PELGER-HUET ANOMALY PRESENT 64 0.4211
40 EPSTEIN-BARR VIRAEMIA 239 0.4178
41 HEPATIC ARTERY THROMBOSIS 93 0.4152
42 CRYPTOSPORIDIOSIS INFECTION 115 0.4064
43 DERMATOPHYTOSIS 81 0.4010
44 ADENOVIRAL HAEMORRHAGIC CYSTITIS 61 0.3961
45 PULMONARY NOCARDIOSIS 88 0.3911
46 HUMAN HERPESVIRUS 8 INFECTION 121 0.3817
47 VIRAL HAEMORRHAGIC CYSTITIS 134 0.3764
48 RENAL TUBULAR ATROPHY 230 0.3692
49 CYTOMEGALOVIRUS ENTERITIS 84 0.3684
50 CYSTITIS VIRAL 64 0.3616
51 NOCARDIOSIS 577 0.3600
52 GRAFT VERSUS HOST DISEASE IN LUNG 114 0.3529
53 CHRONIC GRAFT VERSUS HOST DISEASE IN LIVER 68 0.3523
54 SCEDOSPORIUM INFECTION 139 0.3492
55 ACUTE GRAFT VERSUS HOST DISEASE 1169 0.3445
56 CHRONIC GRAFT VERSUS HOST DISEASE IN SKIN 158 0.3326
57 TRANSPLANT FAILURE 583 0.3312
58 GRAFT VERSUS HOST DISEASE IN SKIN 463 0.3272
59 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 544 0.3213
60 ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE 294 0.3203
61 CHRONIC GRAFT VERSUS HOST DISEASE 754 0.3136
62 ADENOVIRUS INFECTION 556 0.3132
63 GRAFT DYSFUNCTION 89 0.3101
64 BLASTOMYCOSIS 74 0.3096
65 EPSTEIN-BARR VIRUS INFECTION REACTIVATION 100 0.3096
66 LYMPHOCELE 181 0.3089
67 WEST NILE VIRAL INFECTION 143 0.3082
68 HISTOLOGY ABNORMAL 60 0.3030
69 MICROSPORIDIA INFECTION 63 0.3000
70 ACUTE GRAFT VERSUS HOST DISEASE IN LIVER 143 0.2998
71 MUCORMYCOSIS 464 0.2971
72 GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT 373 0.2919
73 ENGRAFTMENT SYNDROME 103 0.2885
74 THROMBOTIC MICROANGIOPATHY 1701 0.2885
75 KIDNEY FIBROSIS 354 0.2871
76 CYTOMEGALOVIRUS INFECTION REACTIVATION 316 0.2870
77 HEPATITIS E 280 0.2840
78 DISSEMINATED CRYPTOCOCCOSIS 101 0.2829
79 RENAL TUBULAR INJURY 119 0.2780
80 FOCAL SEGMENTAL GLOMERULOSCLEROSIS 283 0.2719
81 EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER 308 0.2699
82 MYCOBACTERIUM ABSCESSUS INFECTION 97 0.2694
83 VIRAEMIA 212 0.2684
84 CHOROIDITIS 65 0.2664
85 CYTOMEGALOVIRUS INFECTION 3010 0.2629
86 STRONGYLOIDIASIS 286 0.2621
87 CRYPTOCOCCOSIS 235 0.2608
88 JC VIRUS INFECTION 253 0.2598
89 GRAFT VERSUS HOST DISEASE 1393 0.2548
90 CYTOMEGALOVIRUS HEPATITIS 64 0.2530
91 POST PROCEDURAL BILE LEAK 64 0.2481
92 COMPLICATIONS OF TRANSPLANT SURGERY 110 0.2477
93 GRAFT VERSUS HOST DISEASE IN LIVER 108 0.2466
94 INFECTION REACTIVATION 150 0.2431
95 CEREBRAL ASPERGILLOSIS 102 0.2411
96 TOXOPLASMOSIS 184 0.2323
97 EPSTEIN-BARR VIRUS INFECTION 983 0.2323
98 ALVEOLAR PROTEINOSIS 73 0.2310
99 MICROTIA 66 0.2276
100 PNEUMONIA CYTOMEGALOVIRAL 286 0.2252
101 CYTOMEGALOVIRUS TEST POSITIVE 280 0.2249
102 CYTOMEGALOVIRUS COLITIS 269 0.2106
103 ATYPICAL HAEMOLYTIC URAEMIC SYNDROME 71 0.2082
104 CYTOMEGALOVIRUS ENTEROCOLITIS 92 0.2072
105 DRUG LEVEL FLUCTUATING 134 0.2033
106 HISTOPLASMOSIS DISSEMINATED 164 0.1978
107 ANGIOSARCOMA 66 0.1947
108 VARICELLA ZOSTER VIRUS INFECTION 243 0.1939
109 GLOMERULONEPHRITIS MEMBRANOPROLIFERATIVE 68 0.1932
110 ASPERGILLUS INFECTION 680 0.1918
111 GLOMERULOSCLEROSIS 91 0.1857
112 OSMOTIC DEMYELINATION SYNDROME 89 0.1816
113 SYSTEMIC MYCOSIS 128 0.1816
114 OBLITERATIVE BRONCHIOLITIS 182 0.1765
115 URETERIC STENOSIS 103 0.1752
116 ENTEROCOCCAL INFECTION 563 0.1747
117 ACINETOBACTER INFECTION 130 0.1706
118 HUMAN HERPESVIRUS 6 INFECTION 246 0.1706
119 MENINGITIS CRYPTOCOCCAL 181 0.1690
120 PNEUMONIA CRYPTOCOCCAL 83 0.1673
121 KLEBSIELLA INFECTION 535 0.1671
122 MYCOPLASMA INFECTION 62 0.1671
123 STENOTROPHOMONAS INFECTION 135 0.1640
124 RENAL TRANSPLANT 402 0.1618
125 BRAIN ABSCESS 260 0.1601
126 BRONCHOPULMONARY ASPERGILLOSIS 780 0.1597
127 EPSTEIN-BARR VIRUS TEST POSITIVE 70 0.1549
128 GRAFT COMPLICATION 68 0.1511
129 ENCEPHALITIS VIRAL 132 0.1497
130 INFECTION IN AN IMMUNOCOMPROMISED HOST 70 0.1489
131 PNEUMOCYSTIS JIROVECII INFECTION 84 0.1484
132 CEREBRAL TOXOPLASMOSIS 84 0.1481
133 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 896 0.1477
134 ENTEROCOCCAL SEPSIS 92 0.1463
135 LYMPHOPROLIFERATIVE DISORDER 275 0.1411
136 HAEMOLYTIC URAEMIC SYNDROME 273 0.1387
137 ENTEROCOCCAL BACTERAEMIA 89 0.1376
138 KAPOSI'S SARCOMA 69 0.1372
139 GASTROENTERITIS NOROVIRUS 142 0.1320
140 ACUTE MYELOID LEUKAEMIA RECURRENT 135 0.1318
141 PNEUMONIA PSEUDOMONAL 97 0.1309
142 BILE DUCT STENOSIS 114 0.1300
143 KLEBSIELLA BACTERAEMIA 65 0.1295
144 ENTEROBACTER INFECTION 145 0.1263
145 SECONDARY IMMUNODEFICIENCY 82 0.1250
146 HISTOPLASMOSIS 163 0.1241
147 IGA NEPHROPATHY 103 0.1238
148 CYSTITIS HAEMORRHAGIC 344 0.1237
149 DRUG LEVEL CHANGED 70 0.1213
150 VENOOCCLUSIVE LIVER DISEASE 392 0.1209
151 ASPERGILLOSIS 158 0.1206
152 MYCOBACTERIAL INFECTION 148 0.1198
153 NEPHROPATHY TOXIC 833 0.1195
154 PNEUMOCYSTIS JIROVECII PNEUMONIA 694 0.1193
155 APLASIA PURE RED CELL 299 0.1191
156 PNEUMATOSIS INTESTINALIS 203 0.1171
157 PNEUMONIA KLEBSIELLA 137 0.1166
158 ACTINIC KERATOSIS 223 0.1163
159 LUPUS NEPHRITIS 100 0.1140
160 KLEBSIELLA SEPSIS 87 0.1128
161 FUNGAL SEPSIS 73 0.1125
162 PNEUMONIA INFLUENZAL 76 0.1121
163 ANOGENITAL WARTS 71 0.1109
164 MICROANGIOPATHIC HAEMOLYTIC ANAEMIA 60 0.1109
165 DIFFUSE LARGE B-CELL LYMPHOMA 426 0.1074
166 CYTOMEGALOVIRUS CHORIORETINITIS 136 0.1073
167 MICROANGIOPATHY 72 0.1065
168 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 252 0.1059
169 SYSTEMIC CANDIDA 149 0.1042
170 PARAINFLUENZAE VIRUS INFECTION 95 0.1016
171 PYELONEPHRITIS ACUTE 139 0.1007
172 STEROID DIABETES 60 0.0997
173 URINARY TRACT INFECTION ENTEROCOCCAL 76 0.0993
174 DRUG LEVEL INCREASED 1126 0.0988
175 CHRONIC HEPATITIS 60 0.0968
176 PNEUMOMEDIASTINUM 102 0.0963
177 ESCHERICHIA BACTERAEMIA 130 0.0959
178 PSEUDOMONAS INFECTION 521 0.0956
179 CANDIDA SEPSIS 65 0.0953
180 STEROID WITHDRAWAL SYNDROME 68 0.0948
181 RENAL TUBULAR ACIDOSIS 136 0.0946
182 BACTERIAL SEPSIS 215 0.0922
183 URINARY TRACT INFECTION BACTERIAL 147 0.0916
184 HISTIOCYTOSIS HAEMATOPHAGIC 274 0.0905
185 PNEUMONIA FUNGAL 168 0.0901
186 ESCHERICHIA INFECTION 478 0.0900
187 NORMOCYTIC ANAEMIA 63 0.0899
188 REVERSIBLE POSTERIOR LEUKOENCEPHALOPATHY SYNDROME 68 0.0868
189 VENOOCCLUSIVE DISEASE 150 0.0865
190 RENAL ARTERY STENOSIS 95 0.0861
191 FUNGAEMIA 86 0.0849
192 RENAL TUBULAR NECROSIS 595 0.0840
193 UPPER RESPIRATORY TRACT INFLAMMATION 85 0.0837
194 LIVER TRANSPLANT 227 0.0832
195 TRANSITIONAL CELL CARCINOMA 68 0.0829
196 PULMONARY MYCOSIS 65 0.0820
197 ATYPICAL MYCOBACTERIAL INFECTION 60 0.0816
198 PAPILLOMA VIRAL INFECTION 88 0.0804
199 MYCOBACTERIUM AVIUM COMPLEX INFECTION 126 0.0803
200 DYSPLASIA 66 0.0800
201 GLOMERULONEPHRITIS 127 0.0776
202 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 175 0.0754
203 CENTRAL NERVOUS SYSTEM LYMPHOMA 60 0.0751
204 MULTIPLE ORGAN DYSFUNCTION SYNDROME 1112 0.0741
205 GINGIVAL HYPERTROPHY 64 0.0739
206 COCCIDIOIDOMYCOSIS 62 0.0739
207 DIFFUSE ALVEOLAR DAMAGE 64 0.0736
208 ESCHERICHIA URINARY TRACT INFECTION 222 0.0714
209 SQUAMOUS CELL CARCINOMA OF SKIN 273 0.0710
210 HYPOGAMMAGLOBULINAEMIA 226 0.0703
211 OPPORTUNISTIC INFECTION 93 0.0670
212 FUNGAL SKIN INFECTION 180 0.0664
213 PNEUMOCYSTIS JIROVECI PNEUMONIA 148 0.0662
214 STAPHYLOCOCCAL BACTERAEMIA 182 0.0658
215 LIVER ABSCESS 142 0.0654
216 CHOLANGITIS 251 0.0645
217 HEPATIC FIBROSIS 153 0.0644
218 BILIARY TRACT DISORDER 66 0.0641
219 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 380 0.0631
220 RHINOVIRUS INFECTION 104 0.0630
221 PSEUDOMONAL SEPSIS 76 0.0628
222 PYELONEPHRITIS 373 0.0626
223 BACTERAEMIA 463 0.0617
224 MENINGITIS VIRAL 65 0.0610
225 PNEUMONIA PNEUMOCOCCAL 62 0.0607
226 BONE MARROW TRANSPLANT 76 0.0607
227 OPTIC NEUROPATHY 87 0.0607
228 STEM CELL TRANSPLANT 107 0.0603
229 PNEUMONIA STAPHYLOCOCCAL 89 0.0603
230 ESCHERICHIA SEPSIS 126 0.0595
231 AUTOIMMUNE HAEMOLYTIC ANAEMIA 119 0.0593
232 RENAL TUBULAR DISORDER 136 0.0589
233 OVARIAN CYST 465 0.0581
234 COVID-19 PNEUMONIA 215 0.0576
235 SKIN PAPILLOMA 164 0.0576
236 ORGANISING PNEUMONIA 170 0.0575
237 ENCEPHALITIS 260 0.0568
238 LUNG CONSOLIDATION 117 0.0567
239 MENINGITIS BACTERIAL 59 0.0565
240 NEPHROTIC SYNDROME 270 0.0562
241 DRUG LEVEL DECREASED 326 0.0559
242 LARGE INTESTINAL ULCER 105 0.0549
243 ABDOMINAL INFECTION 91 0.0547
244 HYDRONEPHROSIS 287 0.0540
245 SQUAMOUS CELL CARCINOMA 365 0.0539
246 STAPHYLOCOCCAL SEPSIS 204 0.0528
247 HYPERPARATHYROIDISM SECONDARY 109 0.0523
248 PNEUMONIA BACTERIAL 254 0.0521
249 PATHOGEN RESISTANCE 288 0.0520
250 VARICELLA 93 0.0516
251 LEUKOENCEPHALOPATHY 146 0.0516
252 DRUG LEVEL BELOW THERAPEUTIC 159 0.0513
253 LOW BIRTH WEIGHT BABY 269 0.0510
254 DRUG LEVEL ABOVE THERAPEUTIC 128 0.0509
255 VASCULAR PSEUDOANEURYSM 66 0.0507
256 HERPES SIMPLEX 232 0.0506
257 BONE MARROW TOXICITY 61 0.0502
258 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 179 0.0498
259 PROTEINURIA 598 0.0496
260 PORTAL VEIN THROMBOSIS 114 0.0494
261 NEUROTOXICITY 518 0.0491
262 CANDIDA INFECTION 498 0.0487
263 THROMBOTIC THROMBOCYTOPENIC PURPURA 140 0.0478
264 SEPTIC SHOCK 1385 0.0478
265 NEPHROGENIC SYSTEMIC FIBROSIS 141 0.0472
266 WOUND DEHISCENCE 123 0.0470
267 PNEUMOPERITONEUM 59 0.0462
268 CUSHINGOID 100 0.0459
269 LYMPHADENOPATHY MEDIASTINAL 59 0.0459
270 BLOOD CREATININE INCREASED 2219 0.0459
271 HEPATITIS C 488 0.0455
272 OLIGURIA 214 0.0453
273 ACUTE RESPIRATORY DISTRESS SYNDROME 567 0.0450
274 GRANULOMA 110 0.0448
275 SKIN INDURATION 69 0.0448
276 BLOOD CREATININE ABNORMAL 101 0.0447
277 CLOSTRIDIUM DIFFICILE COLITIS 334 0.0446
278 HYPERURICAEMIA 129 0.0442
279 FOOD ALLERGY 170 0.0440
280 GUILLAIN-BARRE SYNDROME 140 0.0440
281 HEPATIC NECROSIS 137 0.0438
282 OESOPHAGEAL CANDIDIASIS 118 0.0437
283 HYPERAMMONAEMIA 148 0.0436
284 RENAL IMPAIRMENT 2403 0.0434
285 PULMONARY ALVEOLAR HAEMORRHAGE 154 0.0433
286 DISSEMINATED TUBERCULOSIS 78 0.0432
287 CELL DEATH 59 0.0432
288 DERMATITIS ATOPIC 328 0.0429
289 PORTAL HYPERTENSION 93 0.0425
290 SKIN HYPERTROPHY 83 0.0424
291 SERUM SICKNESS 88 0.0423
292 BRAIN HERNIATION 93 0.0420
293 ENTEROCOLITIS 141 0.0419
294 LUNG ADENOCARCINOMA 87 0.0418
295 TOXIC ENCEPHALOPATHY 126 0.0413
296 TUBULOINTERSTITIAL NEPHRITIS 535 0.0413
297 B-CELL LYMPHOMA 108 0.0408
298 HAEMOLYTIC ANAEMIA 279 0.0407
299 ENDOCARDITIS 146 0.0405
300 COVID-19 1353 0.0404
301 LYMPHOPENIA 372 0.0404
302 DYSLIPIDAEMIA 138 0.0399
303 LEUKOPENIA 1391 0.0396
304 UROSEPSIS 252 0.0395
305 SCLERODERMA 108 0.0393
306 PREMATURE DELIVERY 426 0.0392
307 END STAGE RENAL DISEASE 590 0.0387
308 PNEUMONIA VIRAL 77 0.0381
309 CLEFT PALATE 60 0.0379
310 HEPATITIS B 178 0.0378
311 HYPOALBUMINAEMIA 193 0.0378
312 PROSTATITIS 84 0.0374
313 NEPHROGENIC ANAEMIA 149 0.0374
314 BACTERIAL INFECTION 447 0.0373
315 MULTI-ORGAN FAILURE 647 0.0373
316 PRE-ECLAMPSIA 126 0.0371
317 NEPHRITIS 80 0.0368
318 AZOTAEMIA 104 0.0365
319 HAEMODIALYSIS 288 0.0363
320 NOSOCOMIAL INFECTION 64 0.0363
321 APLASTIC ANAEMIA 131 0.0362
322 HEPATOSPLENOMEGALY 72 0.0362
323 HAEMODYNAMIC INSTABILITY 175 0.0362
324 INTRA-ABDOMINAL HAEMORRHAGE 67 0.0360
325 METASTATIC MALIGNANT MELANOMA 59 0.0357
326 ENDOPHTHALMITIS 143 0.0355
327 FIBROSIS 80 0.0351
328 PANCYTOPENIA 1348 0.0350
329 ANURIA 241 0.0350
330 SHOCK HAEMORRHAGIC 193 0.0350
331 PULMONARY TUBERCULOSIS 116 0.0350
332 ENCEPHALOPATHY 581 0.0346
333 ENTERITIS 137 0.0346
334 RESPIRATORY SYNCYTIAL VIRUS INFECTION 121 0.0346
335 CHRONIC MYELOID LEUKAEMIA 114 0.0343
336 GASTROINTESTINAL TOXICITY 89 0.0341
337 BLOOD CREATINE INCREASED 105 0.0341
338 SKIN NECROSIS 136 0.0340
339 HEPATITIS CHOLESTATIC 145 0.0337
340 DISSEMINATED INTRAVASCULAR COAGULATION 374 0.0336
341 HEPATOCELLULAR CARCINOMA 185 0.0336
342 HEPATITIS B REACTIVATION 64 0.0333
343 GASTROENTERITIS 351 0.0332
344 PRODUCT USE IN UNAPPROVED INDICATION 3965 0.0332
345 RESPIRATORY FAILURE 1796 0.0331
346 DISEASE RECURRENCE 539 0.0327
347 PSEUDOMEMBRANOUS COLITIS 60 0.0327
348 PROTEIN URINE PRESENT 113 0.0327
349 OESOPHAGEAL ULCER 98 0.0322
350 DYSMORPHISM 61 0.0321
351 ASCITES 675 0.0318
352 POTENTIATING DRUG INTERACTION 73 0.0318
353 CORONAVIRUS INFECTION 104 0.0317
354 CLOSTRIDIAL INFECTION 97 0.0316
355 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 92 0.0313
356 HAEMOLYSIS 180 0.0312
357 HYPERKALAEMIA 779 0.0311
358 ACUTE LYMPHOCYTIC LEUKAEMIA 63 0.0309
359 BLOOD CULTURE POSITIVE 82 0.0308
360 CYTOPENIA 158 0.0308
361 DRUG RESISTANCE 503 0.0307
362 ACUTE KIDNEY INJURY 2976 0.0305
363 WOUND INFECTION 190 0.0305
364 NECROTISING FASCIITIS 73 0.0305
365 NECROSIS 131 0.0305
366 RENAL FAILURE CHRONIC 234 0.0304
367 DRUG INTERACTION 3529 0.0303
368 NEPHROPATHY 218 0.0303
369 SUBCUTANEOUS ABSCESS 108 0.0303
370 BRONCHIECTASIS 119 0.0302
371 IMMUNOSUPPRESSION 152 0.0301
372 HYPOMAGNESAEMIA 265 0.0300
373 ARTHRITIS BACTERIAL 86 0.0298
374 FAILURE TO THRIVE 123 0.0298
375 NEUROLOGICAL SYMPTOM 117 0.0295
376 URINE OUTPUT DECREASED 202 0.0295
377 THERAPY PARTIAL RESPONDER 101 0.0291
378 SEPSIS 2311 0.0289
379 VIRAL LOAD INCREASED 67 0.0288
380 HERPES VIRUS INFECTION 117 0.0284
381 PULMONARY HAEMORRHAGE 173 0.0281
382 CANDIDIASIS 113 0.0281
383 HEPATIC FAILURE 635 0.0276
384 STAPHYLOCOCCAL INFECTION 701 0.0276
385 CHOLESTASIS 363 0.0276
386 BLOOD UREA INCREASED 378 0.0275
387 POSTOPERATIVE WOUND INFECTION 121 0.0273
388 SPLENOMEGALY 232 0.0272
389 LUNG TRANSPLANT 74 0.0271
390 AUTOIMMUNE HEPATITIS 121 0.0264
391 FUNGAL INFECTION 606 0.0263
392 NORMOCHROMIC NORMOCYTIC ANAEMIA 60 0.0262
393 BONE MARROW FAILURE 470 0.0262
394 HYPERBILIRUBINAEMIA 186 0.0261
395 MYOPATHY 164 0.0260
396 HYPERTRIGLYCERIDAEMIA 104 0.0260
397 ATELECTASIS 195 0.0258
398 GLOMERULAR FILTRATION RATE DECREASED 178 0.0257
399 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 170 0.0252
400 HEART DISEASE CONGENITAL 79 0.0251
401 BASAL CELL CARCINOMA 273 0.0251
402 CATATONIA 86 0.0248
403 ACIDOSIS 142 0.0246
404 PAPULE 97 0.0245
405 BRAIN OEDEMA 225 0.0245
406 PULMONARY MASS 238 0.0244
407 HYPOVOLAEMIA 107 0.0244
408 ABDOMINAL ABSCESS 75 0.0243
409 ACUTE RESPIRATORY FAILURE 297 0.0243
410 ODYNOPHAGIA 97 0.0242
411 LUNG INFILTRATION 183 0.0241
412 MALNUTRITION 181 0.0240
413 LEFT VENTRICULAR HYPERTROPHY 78 0.0240
414 FOETAL GROWTH RESTRICTION 95 0.0238
415 MENINGITIS 113 0.0237
416 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 165 0.0234
417 OTITIS MEDIA 59 0.0233
418 MYASTHENIA GRAVIS 76 0.0232
419 SKIN MASS 96 0.0228
420 AGRANULOCYTOSIS 264 0.0226
421 BLOOD LACTATE DEHYDROGENASE INCREASED 287 0.0226
422 IRON DEFICIENCY ANAEMIA 149 0.0225
423 CARDIAC TAMPONADE 77 0.0224
424 HYDROCEPHALUS 90 0.0224
425 LARGE INTESTINE PERFORATION 114 0.0224
426 INTRACRANIAL PRESSURE INCREASED 89 0.0224
427 STATUS EPILEPTICUS 181 0.0224
428 RENAL CELL CARCINOMA 83 0.0222
429 TYPE 1 DIABETES MELLITUS 86 0.0218
430 METASTASES TO LYMPH NODES 92 0.0218
431 IMMUNE THROMBOCYTOPENIC PURPURA 63 0.0218
432 CLOSTRIDIUM DIFFICILE INFECTION 300 0.0217
433 LUNG INFECTION 340 0.0217
434 ACUTE MYELOID LEUKAEMIA 232 0.0216
435 HEPATIC FUNCTION ABNORMAL 524 0.0216
436 PREMATURE BABY 480 0.0216
437 CACHEXIA 81 0.0216
438 DIALYSIS 241 0.0216
439 MENTAL STATUS CHANGES 453 0.0214
440 INTERSTITIAL LUNG DISEASE 685 0.0214
441 SKIN PLAQUE 111 0.0211
442 SERUM FERRITIN INCREASED 79 0.0211
443 PERICARDIAL EFFUSION 331 0.0211
444 RESPIRATORY DISTRESS 436 0.0210
445 SUBARACHNOID HAEMORRHAGE 154 0.0207
446 DEVICE RELATED INFECTION 248 0.0206
447 SKIN TIGHTNESS 73 0.0205
448 MYELOSUPPRESSION 86 0.0205
449 RENAL FAILURE 2197 0.0205
450 LYMPHOMA 221 0.0204
451 PLEURAL EFFUSION 916 0.0204
452 RENAL FAILURE ACUTE 863 0.0203
453 DEMYELINATION 62 0.0203
454 METASTASIS 95 0.0203
455 METABOLIC ACIDOSIS 426 0.0202
456 VENOUS THROMBOSIS 61 0.0200
457 HYPERGLYCAEMIA 535 0.0199
458 DIABETES MELLITUS 1151 0.0199
459 CEREBRAL ATROPHY 62 0.0198
460 APHTHOUS ULCER 75 0.0198
461 TRANSAMINASES INCREASED 322 0.0198
462 ILEUS 172 0.0197
463 PNEUMOTHORAX 214 0.0197
464 FEBRILE NEUTROPENIA 829 0.0197
465 BLOOD ALBUMIN DECREASED 116 0.0195
466 PULMONARY TOXICITY 74 0.0194
467 PANCREATITIS ACUTE 303 0.0193
468 ILEUS PARALYTIC 61 0.0192
469 SKIN LESION 349 0.0191
470 TUBERCULOSIS 169 0.0190
471 FOLLICULITIS 64 0.0190
472 ELECTROLYTE IMBALANCE 146 0.0189
473 DIARRHOEA HAEMORRHAGIC 125 0.0188
474 HYPERCALCAEMIA 163 0.0187
475 LEUKOCYTOSIS 241 0.0186
476 NEUTROPENIA 1496 0.0186
477 MUCOSAL INFLAMMATION 337 0.0185
478 SKIN INFECTION 132 0.0184
479 METASTASES TO LUNG 137 0.0184
480 ABDOMINAL HERNIA 63 0.0183
481 ORAL CANDIDIASIS 160 0.0183
482 MOUTH ULCERATION 257 0.0182
483 HYPERLIPIDAEMIA 175 0.0182
484 LYMPHADENOPATHY 452 0.0182
485 HEPATIC CIRRHOSIS 226 0.0181
486 ABDOMINAL TENDERNESS 68 0.0180
487 COLITIS 416 0.0180
488 BLOOD MAGNESIUM DECREASED 102 0.0179
489 PREMATURE LABOUR 87 0.0179
490 ACUTE HEPATIC FAILURE 161 0.0179
491 LIVER FUNCTION TEST ABNORMAL 442 0.0178
492 GENERALISED TONIC-CLONIC SEIZURE 182 0.0178
493 SMALL INTESTINAL OBSTRUCTION 153 0.0176
494 PERITONITIS 282 0.0175
495 RENAL DISORDER 575 0.0175
496 STREPTOCOCCAL INFECTION 63 0.0174
497 PLEURISY 83 0.0173
498 SKIN ATROPHY 68 0.0173
499 TOXICITY TO VARIOUS AGENTS 1923 0.0172
500 ANGIOPATHY 76 0.0172
501 THROMBOCYTOPENIA 1313 0.0172
502 LYMPHOCYTE COUNT DECREASED 208 0.0171
503 BLOOD POTASSIUM INCREASED 203 0.0170
504 MALABSORPTION 63 0.0169
505 VENTRICULAR SEPTAL DEFECT 81 0.0169
506 ECZEMA 301 0.0169
507 HYPOXIA 402 0.0167
508 PHOTOSENSITIVITY REACTION 196 0.0165
509 EXPOSURE DURING PREGNANCY 657 0.0165
510 OFF LABEL USE 7167 0.0165
511 OESOPHAGITIS 131 0.0163
512 INTESTINAL ISCHAEMIA 65 0.0163
513 FLUID OVERLOAD 238 0.0162
514 HEPATIC ENCEPHALOPATHY 113 0.0161
515 BLOOD URIC ACID INCREASED 61 0.0159
516 INTENTIONAL PRODUCT USE ISSUE 736 0.0158
517 GASTRIC ULCER 230 0.0158
518 NEUTROPHIL COUNT INCREASED 119 0.0158
519 GLUCOSE TOLERANCE IMPAIRED 62 0.0157
520 HYPOPHOSPHATAEMIA 74 0.0156
521 BLOOD BILIRUBIN INCREASED 324 0.0155
522 TACHYPNOEA 138 0.0155
523 SKIN CANCER 204 0.0155
524 CARDIAC FAILURE ACUTE 65 0.0154
525 ABSCESS 166 0.0154
526 DUODENAL ULCER 81 0.0153
527 ALTERED STATE OF CONSCIOUSNESS 216 0.0153
528 ANAEMIA 2078 0.0150
529 HAEMORRHAGE INTRACRANIAL 182 0.0148
530 PYREXIA 3619 0.0148
531 ADRENAL INSUFFICIENCY 95 0.0148
532 NEUTROPENIC SEPSIS 78 0.0147
533 INTESTINAL PERFORATION 118 0.0147
534 GENERALISED OEDEMA 124 0.0146
535 SHOCK 230 0.0144
536 VIRAL INFECTION 318 0.0144
537 HERPES ZOSTER 579 0.0144
538 HAEMATOCRIT DECREASED 228 0.0144
539 COAGULOPATHY 184 0.0143
540 ACUTE PULMONARY OEDEMA 62 0.0143
541 INFECTION 1307 0.0142
542 MALIGNANT MELANOMA 138 0.0142
543 MYOCARDITIS 84 0.0141
544 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 435 0.0141
545 TREATMENT NONCOMPLIANCE 472 0.0140
546 CONCOMITANT DISEASE AGGRAVATED 64 0.0140
547 PNEUMONITIS 233 0.0139
548 C-REACTIVE PROTEIN INCREASED 324 0.0139
549 URINARY TRACT INFECTION 1568 0.0138
550 OSTEOMYELITIS 193 0.0137
551 BLOOD ALKALINE PHOSPHATASE INCREASED 274 0.0137
552 TENDERNESS 104 0.0136
553 DRUG TOXICITY 186 0.0136
554 HEPATOTOXICITY 195 0.0136
555 POST PROCEDURAL COMPLICATION 195 0.0134
556 MYOSITIS 78 0.0134
557 HEMIPARESIS 178 0.0133
558 HAEMATURIA 352 0.0132
559 CYTOKINE RELEASE SYNDROME 61 0.0132
560 GASTROINTESTINAL INFECTION 77 0.0131
561 PNEUMONIA 2884 0.0131
562 HEPATOMEGALY 102 0.0131
563 LIVER DISORDER 394 0.0130
564 JAUNDICE 280 0.0129
565 ORAL DISORDER 68 0.0128
566 PERITONITIS BACTERIAL 103 0.0128
567 CHRONIC KIDNEY DISEASE 801 0.0128
568 VASCULITIS 100 0.0128
569 CEREBRAL HAEMORRHAGE 342 0.0127
570 RESPIRATORY TRACT INFECTION 212 0.0127
571 INFLAMMATORY BOWEL DISEASE 98 0.0127
572 IMPAIRED GASTRIC EMPTYING 66 0.0127
573 ABORTION INDUCED 96 0.0126
574 POLYURIA 73 0.0126
575 MATERNAL EXPOSURE DURING PREGNANCY 596 0.0125
576 RETINAL HAEMORRHAGE 66 0.0125
577 SPINAL COMPRESSION FRACTURE 81 0.0124
578 CELLULITIS 462 0.0124
579 HAEMATOMA 250 0.0124
580 MYELODYSPLASTIC SYNDROME 132 0.0123
581 INTRAOCULAR PRESSURE INCREASED 119 0.0122
582 GAMMA-GLUTAMYLTRANSFERASE INCREASED 215 0.0121
583 DIABETIC KETOACIDOSIS 211 0.0121
584 CARDIOGENIC SHOCK 110 0.0121
585 SKIN ULCER 223 0.0120
586 HYPERCHOLESTEROLAEMIA 71 0.0120
587 CAESAREAN SECTION 115 0.0119
588 MITRAL VALVE INCOMPETENCE 102 0.0118
589 ARTERIOSCLEROSIS 83 0.0117
590 HAEMOGLOBIN DECREASED 873 0.0116
591 CEREBRAL INFARCTION 214 0.0116
592 MATERNAL DRUGS AFFECTING FOETUS 85 0.0116
593 PULMONARY OEDEMA 377 0.0115
594 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 97 0.0115
595 CENTRAL NERVOUS SYSTEM LESION 129 0.0114
596 PROTHROMBIN TIME PROLONGED 60 0.0114
597 APPENDICITIS 68 0.0113
598 ORAL HERPES 136 0.0112
599 ATAXIA 102 0.0112
600 UVEITIS 83 0.0112
601 MELAENA 187 0.0112
602 COLITIS ULCERATIVE 249 0.0112
603 UPPER RESPIRATORY TRACT INFECTION 356 0.0112
604 PREGNANCY 190 0.0111
605 PNEUMONIA ASPIRATION 193 0.0111
606 NO THERAPEUTIC RESPONSE 135 0.0110
607 HEPATOCELLULAR INJURY 135 0.0110
608 ALANINE AMINOTRANSFERASE INCREASED 504 0.0108
609 PERICARDITIS 78 0.0108
610 OEDEMA 406 0.0107
611 RENAL CYST 65 0.0107
612 GOUT 134 0.0107
613 INFLAMMATION 326 0.0106
614 GASTRITIS 205 0.0106
615 THERAPY NON-RESPONDER 234 0.0106
616 HYPERTENSION 1553 0.0106
617 HYPOCALCAEMIA 139 0.0106
618 MYOCLONUS 93 0.0105
619 CHOLECYSTITIS 91 0.0105
620 IMMUNODEFICIENCY 83 0.0104
621 ANOREXIA 134 0.0104
622 HYPONATRAEMIA 425 0.0103
623 PULMONARY HYPERTENSION 164 0.0103
624 CARDIAC ARREST 648 0.0103
625 PULMONARY FIBROSIS 125 0.0102
626 DRUG-INDUCED LIVER INJURY 161 0.0102
627 HEPATITIS 186 0.0101
628 HEMIPLEGIA 65 0.0101
629 MASS 104 0.0100
630 HAEMOPTYSIS 210 0.0100
631 DELIRIUM 233 0.0100
632 ATRIAL FLUTTER 61 0.0099
633 CARDIAC FAILURE 562 0.0099
634 SUPRAVENTRICULAR TACHYCARDIA 72 0.0099
635 RESPIRATORY DISORDER 212 0.0099
636 ABORTION SPONTANEOUS 305 0.0099
637 IMMUNE SYSTEM DISORDER 87 0.0099
638 METASTASES TO LIVER 116 0.0099
639 ASPARTATE AMINOTRANSFERASE INCREASED 397 0.0099
640 DIARRHOEA 4171 0.0098
641 PHARYNGITIS 90 0.0098
642 ATRIAL SEPTAL DEFECT 68 0.0098
643 GRAND MAL CONVULSION 90 0.0097
644 STOMATITIS 385 0.0097
645 FLANK PAIN 65 0.0097
646 FISTULA 69 0.0096
647 CARDIOMEGALY 99 0.0096
648 PLATELET COUNT DECREASED 689 0.0096
649 CONDITION AGGRAVATED 1681 0.0096
650 TREMOR 1189 0.0096
651 HEPATIC ENZYME INCREASED 415 0.0095
652 SKIN HYPERPIGMENTATION 62 0.0095
653 APHASIA 214 0.0095
654 ACUTE CORONARY SYNDROME 63 0.0095
655 ULCER 107 0.0094
656 LUNG DISORDER 311 0.0094
657 ASPIRATION 70 0.0094
658 HEPATIC STEATOSIS 123 0.0093
659 CARDIOMYOPATHY 103 0.0092
660 NODULE 81 0.0092
661 VENTRICULAR FIBRILLATION 79 0.0092
662 INTESTINAL OBSTRUCTION 226 0.0092
663 CONJUNCTIVITIS 97 0.0091
664 OSTEONECROSIS 248 0.0091
665 FOETAL EXPOSURE DURING PREGNANCY 504 0.0091
666 DEHYDRATION 889 0.0090
667 VENTRICULAR TACHYCARDIA 109 0.0090
668 WHITE BLOOD CELL COUNT INCREASED 261 0.0090
669 GASTROENTERITIS VIRAL 106 0.0090
670 RASH MACULO-PAPULAR 135 0.0089
671 TREATMENT FAILURE 452 0.0089
672 EOSINOPHILIA 105 0.0089
673 EPILEPSY 178 0.0089
674 DERMATITIS 116 0.0088
675 ACNE 528 0.0088
676 ABDOMINAL PAIN 1436 0.0088
677 PURPURA 59 0.0087
678 BRAIN INJURY 61 0.0087
679 GASTROINTESTINAL DISORDER 425 0.0085
680 HALLUCINATION, VISUAL 116 0.0085
681 LIVER INJURY 101 0.0085
682 PRODUCTIVE COUGH 251 0.0085
683 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 63 0.0085
684 SCAB 66 0.0085
685 RENAL INJURY 225 0.0084
686 LIVER FUNCTION TEST INCREASED 101 0.0084
687 DYSURIA 228 0.0084
688 OSTEOPENIA 88 0.0083
689 BLOOD TRIGLYCERIDES INCREASED 115 0.0083
690 TACHYCARDIA 523 0.0083
691 HYPOPHAGIA 143 0.0082
692 KIDNEY INFECTION 110 0.0082
693 HOSPITALISATION 723 0.0082
694 GENERAL PHYSICAL HEALTH DETERIORATION 575 0.0082
695 SYSTEMIC LUPUS ERYTHEMATOSUS 150 0.0082
696 HYPOKALAEMIA 258 0.0081
697 POST PROCEDURAL HAEMORRHAGE 73 0.0081
698 CIRCULATORY COLLAPSE 109 0.0080
699 NERVOUS SYSTEM DISORDER 204 0.0080
700 METASTASES TO BONE 79 0.0080
701 PULMONARY CONGESTION 75 0.0079
702 OBSTRUCTIVE AIRWAYS DISORDER 60 0.0079
703 WHITE BLOOD CELL COUNT DECREASED 566 0.0078
704 IMPAIRED HEALING 171 0.0078
705 GASTROINTESTINAL HAEMORRHAGE 543 0.0078
706 PHOTOPHOBIA 95 0.0077
707 MYOCARDIAL ISCHAEMIA 75 0.0077
708 CONVULSION 439 0.0077
709 DEPRESSED LEVEL OF CONSCIOUSNESS 218 0.0076
710 BLOOD SODIUM DECREASED 102 0.0076
711 DRUG INTOLERANCE 456 0.0076
712 MUSCLE ATROPHY 63 0.0076
713 DRUG EXPOSURE DURING PREGNANCY 258 0.0076
714 DYSPNOEA EXERTIONAL 183 0.0075
715 COMA 264 0.0075
716 PRODUCT USE ISSUE 882 0.0075
717 CARDIO-RESPIRATORY ARREST 248 0.0075
718 THERAPEUTIC RESPONSE DECREASED 299 0.0073
719 ELECTROCARDIOGRAM QT PROLONGED 183 0.0073
720 SKIN DISORDER 153 0.0073
721 SINUS TACHYCARDIA 77 0.0073
722 COLON CANCER 76 0.0073
723 CYSTITIS 172 0.0072
724 DEEP VEIN THROMBOSIS 384 0.0072
725 RED BLOOD CELL COUNT DECREASED 135 0.0070
726 DIPLOPIA 127 0.0070
727 SEIZURE 485 0.0070
728 HAEMORRHOIDS 100 0.0069
729 TOXIC EPIDERMAL NECROLYSIS 73 0.0069
730 NEUTROPHIL COUNT DECREASED 169 0.0069
731 SUBDURAL HAEMATOMA 77 0.0068
732 OEDEMA PERIPHERAL 665 0.0068
733 HAEMATOCHEZIA 234 0.0068
734 ATRIAL FIBRILLATION 465 0.0068
735 PANCREATITIS 264 0.0066
736 HYPOTENSION 938 0.0066
737 DISEASE PROGRESSION 464 0.0066
738 INFLUENZA 464 0.0066
739 BLINDNESS 181 0.0066
740 SLEEP APNOEA SYNDROME 95 0.0066
741 BLOOD PRESSURE SYSTOLIC INCREASED 81 0.0065
742 VOMITING 2133 0.0065
743 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 155 0.0065
744 UNRESPONSIVE TO STIMULI 121 0.0065
745 OSTEOPOROSIS 190 0.0064
746 PRESCRIBED UNDERDOSE 78 0.0064
747 DIABETES MELLITUS INADEQUATE CONTROL 83 0.0064
748 DRUG ERUPTION 75 0.0064
749 CHILLS 527 0.0064
750 DYSARTHRIA 179 0.0063
751 DYSPHAGIA 413 0.0063
752 ABDOMINAL PAIN LOWER 118 0.0063
753 DIVERTICULITIS 120 0.0062
754 CATARACT 240 0.0062
755 ALOPECIA 890 0.0062
756 DRUG DISPENSING ERROR 95 0.0062
757 NEPHROLITHIASIS 187 0.0062
758 CONFUSIONAL STATE 735 0.0062
759 CORONARY ARTERY DISEASE 165 0.0062
760 URINARY RETENTION 145 0.0061
761 VISUAL ACUITY REDUCED 178 0.0061
762 MANIA 76 0.0061
763 SCAR 78 0.0061
764 ISCHAEMIC STROKE 82 0.0060
765 ACUTE MYOCARDIAL INFARCTION 142 0.0060
766 RHABDOMYOLYSIS 184 0.0060
767 NEOPLASM MALIGNANT 262 0.0060
768 PARALYSIS 63 0.0060
769 EAR PAIN 79 0.0059
770 WEIGHT DECREASED 1133 0.0059
771 THROMBOSIS 342 0.0059
772 OXYGEN SATURATION DECREASED 198 0.0058
773 DISORIENTATION 182 0.0058
774 HYPOTHYROIDISM 118 0.0058
775 RASH ERYTHEMATOUS 167 0.0058
776 APPLICATION SITE PAIN 99 0.0057
777 NIGHT SWEATS 122 0.0057
778 COUGH 1028 0.0057
779 LOWER RESPIRATORY TRACT INFECTION 158 0.0056
780 PULMONARY EMBOLISM 423 0.0056
781 CHOLELITHIASIS 139 0.0056
782 FLUID RETENTION 208 0.0056
783 LUNG NEOPLASM MALIGNANT 165 0.0056
784 FOOT FRACTURE 77 0.0056
785 BODY TEMPERATURE INCREASED 84 0.0055
786 HAEMORRHAGE 392 0.0055
787 WOUND 83 0.0054
788 PULMONARY ARTERIAL HYPERTENSION 60 0.0053
789 DECREASED APPETITE 809 0.0053
790 DRUG INEFFECTIVE 4730 0.0053
791 LOCALISED INFECTION 87 0.0052
792 RASH PAPULAR 90 0.0052
793 INCORRECT PRODUCT STORAGE 68 0.0052
794 INTERNATIONAL NORMALISED RATIO INCREASED 134 0.0052
795 BRONCHITIS 288 0.0052
796 MUSCULAR WEAKNESS 420 0.0051
797 DEATH 2946 0.0051
798 BLISTER 187 0.0051
799 FRACTURE 70 0.0050
800 ARRHYTHMIA 180 0.0050
801 RESPIRATORY ARREST 117 0.0050
802 HERNIA 63 0.0050
803 NEURALGIA 79 0.0049
804 PSYCHOTIC DISORDER 108 0.0049
805 BRADYCARDIA 193 0.0049
806 RHEUMATOID ARTHRITIS 356 0.0048
807 SEROTONIN SYNDROME 60 0.0047
808 SKIN EXFOLIATION 255 0.0047
809 ACCIDENTAL OVERDOSE 115 0.0046
810 EYE PAIN 157 0.0046
811 NEUROPATHY PERIPHERAL 272 0.0045
812 ABDOMINAL DISTENSION 325 0.0045
813 LETHARGY 194 0.0045
814 BLOOD PRESSURE DECREASED 211 0.0045
815 PLASMA CELL MYELOMA 112 0.0044
816 ANAPHYLACTIC REACTION 155 0.0044
817 ASTHENIA 1160 0.0044
818 PALLOR 80 0.0044
819 HYPOGLYCAEMIA 161 0.0044
820 SURGERY 148 0.0043
821 LIMB INJURY 74 0.0043
822 BLOOD CREATINE PHOSPHOKINASE INCREASED 100 0.0043
823 RHINORRHOEA 176 0.0043
824 DRY EYE 107 0.0043
825 RASH 1216 0.0043
826 GASTRIC CANCER 69 0.0043
827 SKIN DISCOLOURATION 141 0.0043
828 BLOOD POTASSIUM DECREASED 92 0.0043
829 BLOOD PRESSURE INCREASED 454 0.0042
830 LACTIC ACIDOSIS 86 0.0042
831 HALLUCINATION 212 0.0042
832 DYSPNOEA 1673 0.0042
833 PRURITUS 946 0.0042
834 ABDOMINAL PAIN UPPER 590 0.0042
835 TYPE 2 DIABETES MELLITUS 102 0.0041
836 DEAFNESS 74 0.0041
837 ANGINA PECTORIS 93 0.0041
838 INFUSION RELATED REACTION 151 0.0040
839 GASTROOESOPHAGEAL REFLUX DISEASE 227 0.0040
840 OSTEOARTHRITIS 117 0.0040
841 EYE DISORDER 89 0.0040
842 MENTAL DISORDER 122 0.0040
843 BLOOD CHOLESTEROL INCREASED 130 0.0040
844 VISUAL IMPAIRMENT 317 0.0040
845 NAUSEA 2205 0.0040
846 ORAL PAIN 64 0.0040
847 HAEMATEMESIS 76 0.0039
848 ERYTHEMA 579 0.0039
849 SINUSITIS 272 0.0039
850 RASH MACULAR 90 0.0039
851 MYALGIA 482 0.0039
852 HEADACHE 1735 0.0039
853 AMNESIA 194 0.0039
854 ANGIOEDEMA 119 0.0038
855 LABORATORY TEST ABNORMAL 77 0.0038
856 ANHEDONIA 78 0.0038
857 CARDIAC FAILURE CONGESTIVE 263 0.0037
858 BLOOD GLUCOSE INCREASED 536 0.0037
859 MALAISE 1204 0.0037
860 EAR INFECTION 60 0.0037
861 OVERDOSE 524 0.0037
862 DRUG PRESCRIBING ERROR 70 0.0036
863 CHEST PAIN 506 0.0036
864 DYSPEPSIA 246 0.0036
865 NASOPHARYNGITIS 430 0.0036
866 DISCOMFORT 124 0.0036
867 PAIN OF SKIN 73 0.0036
868 GLYCOSYLATED HAEMOGLOBIN INCREASED 60 0.0036
869 PROCEDURAL PAIN 65 0.0035
870 AGITATION 203 0.0035
871 ABDOMINAL DISCOMFORT 386 0.0035
872 SWELLING 215 0.0035
873 PSORIASIS 303 0.0035
874 EYE PRURITUS 62 0.0035
875 MEDICATION ERROR 141 0.0034
876 BACK PAIN 571 0.0034
877 URINARY INCONTINENCE 75 0.0034
878 COGNITIVE DISORDER 110 0.0034
879 PERIPHERAL SWELLING 324 0.0034
880 PANCREATIC CARCINOMA 68 0.0034
881 LOSS OF CONSCIOUSNESS 322 0.0034
882 OROPHARYNGEAL PAIN 209 0.0034
883 WEIGHT INCREASED 520 0.0034
884 EYE IRRITATION 111 0.0034
885 NASAL CONGESTION 120 0.0033
886 MUSCULOSKELETAL STIFFNESS 195 0.0033
887 SPEECH DISORDER 128 0.0033
888 CONSTIPATION 459 0.0033
889 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 104 0.0033
890 JOINT STIFFNESS 59 0.0032
891 BURNING SENSATION 165 0.0032
892 WHEEZING 119 0.0032
893 RASH PRURITIC 115 0.0032
894 CARDIOVASCULAR DISORDER 70 0.0032
895 PAIN 1265 0.0032
896 BONE PAIN 134 0.0032
897 SLEEP DISORDER 138 0.0031
898 CONTUSION 207 0.0031
899 GAIT DISTURBANCE 431 0.0031
900 DYSKINESIA 93 0.0031
901 TRANSIENT ISCHAEMIC ATTACK 82 0.0031
902 EPISTAXIS 169 0.0031
903 FATIGUE 1585 0.0031
904 OCULAR HYPERAEMIA 87 0.0030
905 RASH GENERALISED 78 0.0030
906 ARTHRITIS 159 0.0030
907 POLLAKIURIA 89 0.0030
908 VISION BLURRED 284 0.0030
909 RECTAL HAEMORRHAGE 96 0.0030
910 INTENTIONAL DRUG MISUSE 62 0.0030
911 HYPOAESTHESIA 320 0.0030
912 DRY SKIN 250 0.0029
913 ARTHRALGIA 780 0.0029
914 MIGRAINE 181 0.0029
915 SWELLING FACE 137 0.0029
916 ROAD TRAFFIC ACCIDENT 88 0.0029
917 VERTIGO 131 0.0029
918 RESTLESSNESS 78 0.0029
919 ABASIA 71 0.0029
920 CARDIAC DISORDER 200 0.0029
921 FEMUR FRACTURE 71 0.0029
922 ILL-DEFINED DISORDER 79 0.0028
923 CEREBROVASCULAR ACCIDENT 378 0.0028
924 PRODUCT SUBSTITUTION ISSUE 121 0.0028
925 PAIN IN EXTREMITY 610 0.0028
926 MUSCULOSKELETAL PAIN 125 0.0027
927 MYOCARDIAL INFARCTION 408 0.0027
928 INSOMNIA 536 0.0027
929 ASTHMA 177 0.0027
930 GASTRIC DISORDER 80 0.0026
931 PARAESTHESIA 301 0.0026
932 ADVERSE DRUG REACTION 136 0.0026
933 THERAPY CESSATION 86 0.0026
934 CHEST DISCOMFORT 182 0.0026
935 DEPRESSION 458 0.0026
936 HEART RATE INCREASED 180 0.0026
937 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 169 0.0026
938 SYNCOPE 188 0.0025
939 LIP SWELLING 60 0.0025
940 NECK PAIN 99 0.0025
941 MOBILITY DECREASED 120 0.0025
942 STRESS 119 0.0025
943 PALPITATIONS 206 0.0025
944 UNEVALUABLE EVENT 139 0.0024
945 FALL 570 0.0024
946 SOMNOLENCE 348 0.0024
947 INTENTIONAL PRODUCT MISUSE 144 0.0024
948 PRODUCT DOSE OMISSION ISSUE 143 0.0024
949 HYPOACUSIS 63 0.0024
950 URTICARIA 269 0.0024
951 INFLUENZA LIKE ILLNESS 154 0.0024
952 FEELING HOT 103 0.0024
953 DRUG ADMINISTRATION ERROR 73 0.0024
954 MEMORY IMPAIRMENT 222 0.0023
955 DEPRESSED MOOD 82 0.0023
956 IRRITABILITY 107 0.0023
957 JOINT SWELLING 173 0.0023
958 MUSCLE SPASMS 296 0.0022
959 ANXIETY 462 0.0022
960 EMOTIONAL DISTRESS 145 0.0022
961 DYSPHONIA 87 0.0022
962 FLATULENCE 86 0.0022
963 HYPERSENSITIVITY 279 0.0022
964 HYPERHIDROSIS 203 0.0021
965 MALIGNANT NEOPLASM PROGRESSION 135 0.0021
966 BLOOD GLUCOSE DECREASED 79 0.0021
967 DIZZINESS 739 0.0021
968 INJURY 119 0.0021
969 NO ADVERSE EVENT 189 0.0020
970 TINNITUS 66 0.0020
971 PRODUCT DOSE OMISSION 134 0.0020
972 INCORRECT DOSE ADMINISTERED 228 0.0020
973 DISTURBANCE IN ATTENTION 80 0.0020
974 ABNORMAL BEHAVIOUR 66 0.0020
975 DRUG EFFECT INCOMPLETE 71 0.0019
976 BALANCE DISORDER 120 0.0019
977 AGGRESSION 73 0.0018
978 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 130 0.0018
979 WRONG TECHNIQUE IN DRUG USAGE PROCESS 65 0.0018
980 DRUG EFFECT DECREASED 95 0.0018
981 ADVERSE EVENT 111 0.0017
982 DRY MOUTH 95 0.0017
983 SKIN BURNING SENSATION 90 0.0016
984 ARTHROPATHY 60 0.0016
985 DRUG HYPERSENSITIVITY 228 0.0016
986 PROSTATE CANCER 76 0.0015
987 NERVOUSNESS 61 0.0014
988 SUICIDAL IDEATION 97 0.0014
989 FEELING ABNORMAL 243 0.0013
990 DRUG DOSE OMISSION 204 0.0012
991 FLUSHING 96 0.0012
992 PRODUCT QUALITY ISSUE 122 0.0011
993 BREAST CANCER 75 0.0010
994 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 97 0.0009
995 INJECTION SITE PAIN 118 0.0006